Head of UNAIDS Warns Against Overly TRIPS-Plus IP Provisions in the India-EU Free Trade Agreement
UNAIDS Executive Director Michel Sidibe has warned against the inclusion of TRIPS-Plus provisions in the EU-India Free Trade Agreement that would jeopardize the continued manufacture and export of generic medicines. India currently produces the majority of antiretrovirals used in the…
